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S ince Shealy et al.  [1] reported a successful case of dorsal column stimulation (currently known as 
spinal cord stimulation or SCS) for the treatment of 
cancer pain in 1967,  the effectiveness of SCS for 
chronic intractable pain has been investigated [2 , 3].  
The more recent development of SCS has depended 
largely on improvements of the stimulation devices’ 
components such as electrodes and generators.  Two 
different types of electrical stimulators are currently 
available: constant current (CC) systems and constant 
voltage (CV) systems.  The first successful case of SCS 
was performed using a CV system in 1967 [1],  and a 
CC system was first used in 1997.  Subsequently,  several 
studies have shown the efficacy of both CV systems and 
CC systems [4 , 5].
For effective pain relief,  it is necessary to provide 
sufficient coverage of the affected area with the pares-
thesia induced by SCS [6-8].  Since the method of stim-
ulation differs between CC and CV systems,  the range 
of paresthesia induced by the 2 methods is thought to 
differ even when the electrode is placed at the same 
position.  A CV system supplies fixed (i.e.,  constant) 
voltage by varying the amount of current,  depending 
on changes in the resistance.  Conversely,  a CC system 
supplies a constant current by adjusting the voltage in 
response to resistance.  Therefore,  if the resistance 
increases during SCS,  a CC system provides constant 
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Although spinal cord stimulation (SCS) is a useful treatment for chronic intractable pain,  the optimal method 
of stimulation has not yet been established.  In this prospective,  crossover study,  we compared the efficacy of 
using a constant current (CC) system with that of a constant voltage (CV) system for temporal SCS.  Twenty 
patients were enrolled and divided into two groups.  For 10 patients,  a CV system was applied on Days 1-5,  fol-
lowed by the use of a CC system on Days 6-10.  For the other 10 patients,  a CC system was applied for the first 
five days,  followed by a CV system for the subsequent five days.  We evaluated the alteration of pain intensity 
using a visual analogue scale (VAS),  the area of stimulation,  the stability of effect,  and patient satisfaction 
regarding treatment.  The pain scores decreased significantly after the start of the SCS.  There was no significant 
difference in the change in VAS between the two systems.  The stimulation method used for temporal SCS did 
not affect the reduction of pain intensity.  Patients felt a wider stimulation area by the CC system compared to 
the CV system.
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current,  whereas in a CV system the current decreases 
as the resistance increases.  As a CV system delivers the 
maximum current at the start of stimulation,  its efficacy 
may decrease as the resistance increases.  Although dif-
fering efficacies of CC and CV systems have been 
reported [9 , 10],  these results have been controversial.
In this prospective,  crossover study,  we investigated 
whether a CC system and a CV system in SCS used to 
treat intractable pain differed with regard to analgesic 
efficacy and patient preference.
Methods
This study was approved by the institutional ethics 
committee of Kobe University (Approval No.  1227).  
Written,  informed consent was obtained from all 
patients,  and the study was performed in accordance 
with the principles outlined in the Declaration of 
Helsinki.
Patients. Patients with chronic intractable pain 
participated in this prospective crossover study.  They 
were recruited by several physicians at Kobe University 
Hospital.  All patients had been diagnosed with neuro-
pathic pain resistant to both pharmacological treatment 
(including anti-inflammatory drugs,  opioids,  antide-
pressants,  and anticonvulsants) and nerve block ther-
apy.  Only patients who had pain with a spinal nerve 
distribution were selected; patients with head,  neck,  
and/or facial pain were excluded.  Patients with blood 
coagulation abnormalities and psychiatric disorders 
were also excluded.
We divided the patients into 2 groups,  according to 
the method of SCS employed.  Patients were randomly 
assigned to the groups according to a computer-gener-
ated sequence contained in sealed,  opaque envelopes.
Spinal cord stimulation. Percutaneous SCS was 
performed on all patients.  Stimulation was applied 
through a lead inserted percutaneously via X-ray guid-
ance with the patient in the prone position (Fig. 1).  The 
lead had quadripolar electrodes,  and stimulation was 
produced by an extracorporeal device.  For the CV 
system,  an extracorporeal device manufactured by 
Medtronic (Screening Stimulator,  Minneapolis,  MN,  
USA) was used,  and for the CC system,  an extracorpo-
real device manufactured by St. Jude Medical 
(Multiprogram Trial Stimulator,  St. Paul,  MN,  USA) 
was used.  The lead was placed at the appropriate site to 
provide 80% coverage of the affected area (Fig. 2).  
Patients were asked to draw their pain distributions,  
and these diagrams were referenced to achieve precise 
coverage of the affected area by carefully adjusting stim-
ulator parameters.
SCS was carried out for 10 days in all patients.  We 
divided the patients randomly into 2 groups of 10 each 
for a crossover study.  One group patients had a CV sys-
tem applied from Day 1 to Day 5; this was changed to a 
CC system from Day 6 to Day 10 (the CV-CC group).  
The other group had the CC system applied for the first 
5 days,  and then the CV system was applied for the 
next 5 days (the CC-CV group) (Fig. 3).
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Fig. 1　 The spinal cord stimulation (SCS) lead insertion proce-
dure.
Fig. 2　 Example of staggered lead placement in SCS.
The stimulation parameters (intensity,  frequency,  
and pulse-width) were set on the first day of SCS lead 
insertion,  and this was not changed during the study 
period.
Pain evaluation. We evaluated the change in the 
patients’ pain intensity with the use of a visual analogue 
scale (VAS); the patients’ scoring on the VAS was used 
as the primary outcome.  We also recorded the area of 
stimulation,  the stability of the effect,  and patient satis-
faction regarding SCS treatment as secondary out-
comes.
VAS. The attending physician at our pain clinic 
recorded the VAS for each patient at the patient’s initial 
examination.  A 100-mm scale plate was used to assess 
the patients’ VAS score,  where 0 mm indicated no pain,  
and 100 mm indicated maximal pain.  During the 
study,  the daily average VAS of each patient was 
recorded before he or she went to bed.
Area of stimulation. For effective analgesia,  the 
area of stimulation must cover the affected region pre-
cisely.  However,  the area where stimulation is obtained 
varies according to the patient’s posture and/or activi-
ties of daily living.  We therefore asked the patients 
which system provided the most appropriate cover on 
the last day of their SCS (the tenth day from inception 
of SCS).
Stability of effect. Because patients with chronic,  
intractable pain have been suffering for a long time,  it is 
crucial to determine whether or not the effect of SCS is 
stable.  Patients were thus asked on the last day of SCS 
which stimulation method had provided the most stable 
effect on their pain.
Patient satisfaction. We also asked the patients 
which system provided the most satisfactory pain relief.
Statistical analysis. Data are expressed as means 
(95% confidence interval,  95%CI) or n (%).  The com-
parisons of the 2 groups’ data was done using the t-test 
and Fisher’s exact test.  To compare the change in VAS 
values between the 2 groups,  we performed a two-way,  
repeated analysis of variance (ANOVA) test.  A p-value 
< 0.05 was considered significant.  Statistical analyses 
were performed using SPSS software,  ver. 20.0.
Results
Patient characteristics. Twenty patients with 
chronic intractable pain participated; their characteris-
tics are summarized in Table 1.  We randomly divided 
the patients into a CV-CC group and a CC-CV group of 
10 patients each.  The patients’ ages ranged from 44 to 
81 years,  with a mean (95%CI) of 67.8 (62.0, 73.5) 
years.  There was no significant difference in age 
between the 2 groups.  Six were male (30%),  14 were 
female (70%) and there were also no significant differ-
ences in sex between the 2 groups.  
Post-herpetic neuralgia (PHN) was the most preva-
lent diagnosis,  occurring in 8 patients (40%),  followed 
by spinal canal stenosis in 5 patients (25%).  Of the lat-
ter,  4 patients had lumbar stenosis and one had cervical 
stenosis.  Patients with cervical and lumbar spinal canal 
stenosis were diagnosed as having neuropathic pain 
with unilateral or focal radiculopathy.  Three patients 
(15%) were diagnosed with complex regional pain syn-
drome,  and 3 others (15%) were diagnosed with failed 
back surgery syndrome.  One patient was diagnosed 
with peripheral neuropathy (5%).  There was no signifi-
cant difference between the 2 groups regarding diagnosis.
Regarding the affected regions,  12 patients (60%) 
had a lumbar spinal nerve distribution of pain,  fol-
lowed by 4 patients with a cervical distribution and 
another 4 with a thoracic distribution.  There was no 
significant difference between the 2 groups regarding 
the distribution of pain.  The mean (95%CI) duration of 
onset of disease to the commencement of SCS in the 
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Fig.  3　 Patients were randomized into 2 groups (n=10 each).  
The CV-CC group received 5 consecutive days of stimulation by the 
constant voltage (CV) system followed by 5 consecutive days of 
stimulation by the constant current (CC) system.  The CC-CV group 
received 5 consecutive days of stimulation by the CC system 
followed by 5 consecutive days of stimulation by the CV system.
CV-CC group was 12.5 (4.9,  20.1) months.  In the 
CC-CV group this was 11.4 (1.3,  21.5) months.  The 
difference in duration between the 2 groups was not 
significant.
Analgesic effect (Change in VAS). The mean 
(95%CI) VAS of all patients at their initial consultations 
at our hospital was 85.3 (74.5,  96.0) and did not differ 
significantly between the 2 groups: The mean (95%CI) 
in the CV-CC group was 89.5 (78.9,  100.1),  whereas in 
the CC-CV group this was 81.0 (63.6,  98.4).  After the 
first visit,  the VAS of all patients decreased gradually 
after treatment with medication and/or neural blockade.  
The VAS immediately prior to the present study com-
mencement was 57.5 (42.1,  72.9) in the CV-CC group 
and 58.0 (45.2,  70.8) in the CC-CV group,  with no 
significant difference between the 2 groups (Table 1).  
During the 10-day study period,  the VAS scores 
decreased significantly after the start if SCS in both 
groups (p < 0.001) (Fig. 4).  However,  there was no sig-
nificant difference in the change in VAS during the 
study period between the 2 groups (p= 0.57) (Fig. 4).  We 
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Table 1　 Patient characteristics
CV-CC group
(n=10)
CC-CV group 
(n=10) p-value
Age (years) 65.4 (58.1,  72.7) 70.1 (62,  78.2) 0.41
Males : females 4 :6 2 :8 0.63
Diagnosis
0.79
PHN 3 (30%) 5 (50%)
LSCS 2 (20%) 2 (20%)
CRPS 2 (20%) 1 (10%)
Others 3 (30%) 2 (20%)
Pain location
0.51
Cervical 1 (10%) 3 (30%)
Thoracic 2 (20%) 2 (20%)
Lumber 7 (70%) 5 (50%)
VAS at initial consultation 89.5 (78.9,  100.1) 81 (63.6,  98.4) 0.42
VAS before SCS placement 57.5 (42.1,  72.9) 58 (45.2,  70.8) 0.96
Duration from onset to study 12.5 (4.9,  20.1) 11.4 (1.3,  21.5) 0.87
Duration from onset to study 12.5 (4.9,  20.1) 11.4 (1.3,  21.5) 0.87
Data are presented as n (%) or mean (95%CI),  as appropriate.  CV,  constant voltage; CC,  constant current; PHN,  post-herpetic neural-
gia; LSCS,  lumbar spinal canal stenosis; CRPS,  complex regional pain syndrome; VAS,  visual analogue scale; SCS,  spinal cord stim-
ulation.
*Others: 3 patients had Failed Back Surgery Syndrome,  1 patient had cervical spinal stenosis,  and 1 patient had peripheral neuropathy.
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Fig.  4　 Time course of analgesic eﬀect.  Gray bar: The sequential 
changes in the visual analog scale (VAS) during SCS in the CV-CC 
group.  White bar: The change in VAS during SCS in the CC-CV 
group.  There was a signiﬁcant change in VAS during the time 
course (p=0.016).  However,  there was no signiﬁcant diﬀerence 
between the 2 groups (p=0.49).
compared the VAS scores between the 2 groups during 
the CV system usage and that of the CC system (Fig. 5).  
No significant difference in the VAS scores was revealed 
between the uses of CV and CC (p = 0.8).
Area of stimulation. Regarding the area of stim-
ulation,  each patient was asked on the last day of the 
study whether they reported better coverage of the 
affected area during the first 5 days or the last 5 days.  
Eight patients (40%) reported that the CC system was 
superior to the CV system in this regard.  No patient 
reported that the CV system was superior.  Twelve 
patients reported that there was no difference between 
the 2 systems (60%).  The CC system was significantly 
better than the CV system regarding the area of stimu-
lation provided (p = 0.005) (Table 2).  The voltage in the 
CV system ranged from 1.5 to 6.0 V,  and the electric 
current in the CC system ranged from 1.5 to 4.0 mA.
Stability of effect. Nine patients reported that the 
CC system provided greater stability of effect than the 
CV system (45%).  Four patients reported that CV sys-
tem was more stable than the CC system (20%).  Seven 
patients reported no difference between the CC and CV 
systems (35%).  There was no significant difference in 
the stability of effect between the CV and CC systems 
(p = 0.17) (Table 2).
Patient satisfaction regarding SCS treatment.
Four patients preferred the CV system (20%) whereas 
9 preferred the CC system (45%).  Seven patients reported 
no difference between the CC and CV systems.  There 
was no significant difference in patient satisfaction 
between the CV and CC systems (p = 0. 17) (Table 2).
Discussion
We compared the efficacy of a CC system and a CV 
system for providing temporal SCS for intractable pain.  
Both systems provided significant decreases in reported 
pain scores after the commencement of SCS.  However,  
there was no significant difference between the 2 systems 
regarding the change in VAS.  While patient satisfaction 
and effect stability did not differ between the systems,  
the area of stimulation provided by the CC system was 
larger than that provided by the CV system.
The mechanism of analgesic efficacy in SCS is based 
on Melzack’s gate control theory [11].  SCS may modu-
late pain signal inputs by covering the painful area with 
impulses traveling in the opposite direction to pain 
signals originating from the dorsal column [2 , 12 , 13].  
For effective treatment,  it is very important that the 
dorsal column is precisely stimulated.  Schade et al.  
used 15 sec of constant current or constant voltage 
stimulation to evaluate whether patients could detect a 
difference in the paresthesia induced by SCS [9].  In the 
present study,  we examined patients for 2 periods of 
5 days each,  during which they received treatment with 
either the CV or CC system followed by a crossover.  We 
then compared the efficacy of pain reduction,  the sta-
bility of stimulation,  the area of stimulation,  and 
patient satisfaction.  There was no significant difference 
between the 2 systems in analgesic efficacy as measured 
by the VAS.  This suggests that the type of SCS system 
employed has no impact on analgesic efficacy when the 
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Table 2　 Outcome assessment 
CV>CC CV=CC CV<CC p-value
Stability of stimulation 4/20 (20%) 7/20 (35%) 9/20 (45%) 0.17
Area of stimulation 0/20 (0%) 12/20 (60%) 8/20 (40%) 0.005
Patient satisfaction 4/20 (20%) 7/20 (35%) 9/20 (45%) 0.17
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Fig.  5　 Summary of the analgesic eﬀects.  The black bar 
indicates sequential changes in VAS during SCS by the CV system.  
Gray bar: The change in VAS during SCS by the CC system.  
There was no signiﬁcant diﬀerence between the analgesic eﬀect 
provided by the CV and CC systems (p=0.80).
same stimulation parameters (site of electrode,  pulse-
width,  frequency,  and amplitude) are set.  
Most previous clinical studies investigating the effec-
tiveness of SCS have looked at either a CC system or a 
CV system.  There are few reports comparing the effi-
cacy of both systems.  Some recent studies evaluated the 
differences between a CC system and a CV system.  
Washburn et al.  treated 30 patients with SCS using 
either a CC system or a CV system for 3 days each,  and 
they reported that many patients preferred the CC sys-
tem over the CV system,  and that CC system reduced 
pain scores to a greater degree compared to the CV 
system [10].  Other reports have indicated that many 
patients did not experience any difference between the 
2 systems [9],  with only a few differences in efficacy 
reported [12].  How the type of stimulation system mod-
ulates analgesic effects remains a matter of controversy.  
During the use of a CV system,  the electrical cur-
rent varies depending on tissue resistance,  while the 
voltage remains constant.  Conversely,  a CC system 
provides a constant current flow by regulating the volt-
age according to the tissue resistance.  This may be the 
reason why a CC system can achieve greater stability 
than a CV system,  as well as why a CC system may pro-
vide superior analgesia.  In our study,  however,  there 
was no significant difference in pain scores VAS or the 
stability of stimulation achieved.  We speculate that 
there may be 2 reasons for this result.  
First,  although the pulse shape in 1 msec in response 
to resistance differs electrically between a CC system 
and a CV system,  there is no physiologic difference 
between the 2 systems because the amount of energy 
that spreads due to stimulation is small,  and the electric 
current that reaches the spinal cord is < 10% of the total 
current [14].  Second,  the primary factor determining 
whether or not neurons are stimulated is the amount of 
charge (pulse width × amplitude),  not the type of stim-
ulation system used.  It is our opinion that the primary 
outcome that we measured VAS was influenced by these 
2 factors.  
In this study,  we evaluated 3 additional parameters 
as secondary outcomes (the area of stimulation,  the 
stability of stimulation,  and patient satisfaction) to 
compare the differences between the CC and CV sys-
tems in detail.  The only significant difference revealed 
was that the CC system provided a wider area of stimu-
lation than the CV system.  A CC system produces a 
rectangular-shaped voltage pulse because the voltage,  
rather than the current,  changes in response to the 
resistance.  A CV system,  in contrast,  delivers a spike-
shaped pulse (which results from a steep rise at the 
beginning of the pulse) and a slow decay of the resultant 
current,  in response to resistance.  
Several studies suggested that different pulse shapes 
can selectively activate nerve fibers of varying diameters 
under specific conditions [15-18].  The spiked pulses of 
a CV system may not be ideal for activating the Aβ 
fibers associated with touch sensation within the dorsal 
columns,  and these pulses may be painful,  especially at 
the beginning of the pulse.  With a CC system,  
increased stimulation may result in a greater area of 
analgesic cover.  These factors may explain the wider 
coverage achieved when the CC system was used in the 
present study.  
Regarding patient satisfaction,  our patients’ reports 
showed no significant difference between the CC and 
CV systems.  Patient satisfaction is influenced by factors 
such as the patient’s backgrounds,  previous treatment,  
and the severity and intensity of pain.  We suspect that 
the main reason why patient satisfaction did not differ 
between the 2 groups was that the 2 systems provided 
equivalent analgesic efficacy.  
There are several limitations to this study.  First,  this 
was a single-center study,  with a small number (n = 20) 
of eligible participants,  i.e.,  patients with intractable 
pain resistant to multiple treatment modalities.  
However,  this is a greater number of patients compared 
to previous reports.  Second,  we evaluated patients with 
a chronic condition for a limited period (10 days),  but 
SCS for a chronic pain is applied over a period of 
months or years.  When resistance to SCS therapy 
develops during a longer period,  a CC system may be 
favorable as it can provide constant current.  Further 
studies examining subjects over a longer period are 
required.  Third,  although we evaluated the differences 
between 2 systems by looking at 4 factors,  many other 
variables should be considered to comprehensively 
evaluate pain profiles.  Finally,  we were unable to com-
pare amplitude and resistance values and changes 
between the 2 systems.  Different results may have been 
recorded if we had altered stimulation settings.  
In conclusion,  the type of stimulation method 
employed did not affect analgesic efficacy.  There were 
no significant differences between the CC system and 
the CV system regarding patient satisfaction and the 
stability of stimulation.  A CC system might provide a 
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greater area of coverage compared to CV systems.
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